Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Journal Club: The 2023 WHF Consensus Document on ATTR-CM
1b) We are honoured to have as our guest expert faculty Fausto Pinto MD PhD @fjpinto1960, Diretor do Serviço de Cardiologia do @ulssanta_maria;...
Journal Club: Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
2) The article is at 🔓https://t.co/pcn3xUfoWf and our content expert for this program is the 1⃣st author, Kevin Sheth MD @sheth_kevin, Professor of...
ATTR-PN: A Primer
2) Our expert first-time @cardiomet_ve author is Dra. Lucía Galán Dávila @lucia_galan, Especialista de área Neurologiaat Hospital Clinico San Carlos...
Barriers to Care in Achieving Early Rhythm Control in Atrial Fibrillation
2) @naijaQRS is a cardiac #electrophysiologist at Cardiology Associates of Fredericksburg, Virginia 🇺🇸. He is passionate about #EP, #mentoring, and...
Live Tweetorial from ISC24: PREDICTORS OF HEMATOMA EXPANSION AND RESPONSE TO ANDEXANET IN ANNEXa-I
2) Our returning expert author is #ANNEXa_I investigator Ashkan Shoamanesh MD @Ash_Shoamanesh, #Stroke #Neurologist @HamHealthSci, Assoc Prof...
Cancer Associated Thrombosis: Current and Future Treatment Strategies, Assessing Relative Risk Among Cancer Types
2a) The program is intended for #healthcare professionals & supported by an independent educational grant from Anthos Therapeutics. Statement of...
PAH Alphabet Soup: The Clinical Implications of Understanding the NO-sGC-cGMP Pathway
2) This program for #healthcare providers is supported by an unrestricted educational grant from Bayer. Statement of accreditation & faculty...
Lessons to Be Learned from the Report of the First UK Experience with Andexanet Alfa in Acute Aortic Syndrome
2) This program is a #journalclub. The reviewed article is at https://t.co/TwtVzbcO82. It comes from the Golden Jubilee National Hospital,...
Revisiting the “FXI Hypothesis” after AHA23 and the Early Termination of OCEANIC-AF
2) That prior program shared and explained the results of the #LBCT data from #AZALEA_TIMI_71 at #AHA23. Lots has happened in the #FXI world since...
Determination of the Risk of Stroke in Patients with Atrial Fibrillation and Cancer: Current and Emerging Paradigm
1b) With the burgeoning #AFib population worldwide, effective #SPAF is hindered by #adherence issues, #underprescribing, & #underdosing....
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.